Futura Medical (LON:FUM) Shares Down 13% – Here’s What Happened

Futura Medical plc (LON:FUM) shares dropped 13% during trading on Wednesday . The stock traded as low as GBX 8.51 ($0.11) and last traded at GBX 8.67 ($0.12). Approximately 263,638 shares traded hands during trading, a decline of 57% from the average daily volume of 606,483 shares. The stock had previously closed at GBX 9.96 ($0.13).

Futura Medical Stock Performance

The stock has a market capitalization of £27.12 million, a price-to-earnings ratio of -7.18 and a beta of 1.25. The company has a fifty day simple moving average of GBX 9.63 and a 200 day simple moving average of GBX 21.43.

Futura Medical (LON:FUM) last issued its quarterly earnings data on Tuesday, April 15th. The company reported GBX 0.43 ($0.01) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 56.44% and a negative net margin of 44.64%. As a group, equities analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

About Futura Medical

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.